THE COMPARISON / A CLOSER LOOK

CrewAI Enterprise vs Dify

Compare the listed plans, useful capabilities, and practical tradeoffs.

Prices and features reflect editorial records. Check vendor terms before you buy; documentary checks do not imply hands-on testing.

CrewAI Enterprise

AI Tools for Business

CrewAI Enterprise is the paid, production-ready tier of CrewAI's Agent Management Platform (AMP): dedicated VPC or BYOC deployment, SSO, RBAC, unlimited…

SOURCE-CHECK COVERAGE

No scoped source-check record shown. Check current pricing and vendor terms before buying.

Starting Price

Contact

Dify

🟡Low Code

LLM application platform

Dify review covering visual LLM workflows, agents, RAG, self-hosting, verified cloud pricing, deployment tradeoffs, practical use cases, pros, and cons.

SOURCE-CHECK COVERAGE

No scoped source-check record shown. Check current pricing and vendor terms before buying.

Starting Price

Free

Feature Comparison

Focus the table and use arrow keys to scroll when columns extend beyond the screen.

FeatureCrewAI EnterpriseDify
CategoryAI Tools for BusinessLLM application platform
Pricing Plans2 listed plans4 listed plans
Starting PriceContactFree
Key Features
  • • Visual Workflow Builder
  • • One-Click Deployment
  • • Operational Monitoring
  • • Agentic workflow builder for LLM applications
  • • Chatbot and assistant development workflows
  • • RAG-backed app patterns for knowledge products

The editorial take

Choose CrewAI Enterprise for true multi-agent crews with role/task abstractions, regulated-industry compliance certifications, and managed Kubernetes deployment at Fortune 500 scale. Choose Dify if you primarily need an LLMOps platform for single-agent chatbots, RAG applications, and prompt management, and you want a more affordable self-hosted option with a strong free tier and faster time-to-first-deploy.

CrewAI Enterprise - Pros & Cons

Pros

  • ✓Same open-source runtime as /tools/crewai — no proprietary lock-in on agent code
  • ✓Governed control plane with RBAC, audit trails, and PII redaction hooks built in
  • ✓FedRAMP High and SAM certified deployment paths for regulated buyers
  • ✓Deep evaluation integrations (Arize, Galileo, Datadog, Patronus) — not just tracing
  • ✓Named support and on-site training reduce time-to-production for large teams

Cons

  • ✗Pricing is Custom-only — no self-serve mid-tier for teams too big for Free, too small for Enterprise
  • ✗Requires a sales conversation before you can evaluate real cost
  • ✗Discovery engine's automation ranking depends on quality of your ticket/chat integration
  • ✗Enterprise setup (VPC/BYOC) adds cloud-engineering effort vs a SaaS-only competitor

Dify - Pros & Cons

Pros

  • ✓Combines workflow, knowledge, testing, and deployment
  • ✓Open-source edition enables self-hosting
  • ✓Multiple providers reduce model lock-in
  • ✓Visual graphs aid cross-functional collaboration

Cons

  • ✗Self-hosting shifts upgrades, security, backups, and scaling to customers
  • ✗Message credits do not include every model or infrastructure cost
  • ✗Large visual graphs become hard to review
  • ✗RAG still requires retrieval evaluation and data governance

Not sure which to pick?

🎯 Take our quiz →

🔒 Security & Compliance Comparison

Focus the table and use arrow keys to scroll when columns extend beyond the screen.

Security FeatureCrewAI EnterpriseDify
SOC2——
GDPR——
HIPAA——
SSO—✅ Yes
Self-Hosted—✅ Yes
On-Prem—✅ Yes
RBAC—✅ Yes
Audit Log—✅ Yes
Open Source—✅ Yes
API Key Auth—✅ Yes
Encryption at Rest—✅ Yes
Encryption in Transit—✅ Yes
Data Residency——
Data Retention—configurable
🦞

New to AI tools?

Read practical guides for choosing and using AI tools

🔔

Price Alert Interest

Record the tools you want pricing updates for

Selected 2 tools

Registration records your interest; an alert schedule and email delivery are not confirmed.

Get weekly AI agent tool insights

Comparisons, new tool launches, and expert recommendations delivered to your inbox.

No spam. Unsubscribe anytime.

Ready to Choose?

Read the full reviews to make an informed decision